Lanean...
Metallothionein-1G Facilitates Sorafenib Resistance through Inhibition of Ferroptosis
Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide and currently has the fastest rising incidence of all cancers. Sorafenib was originally identified as an inhibitor of multiple oncogenic kinases and remains the only approved systemic therapy for advanced HCC. However,...
Gorde:
| Argitaratua izan da: | Hepatology |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956496/ https://ncbi.nlm.nih.gov/pubmed/27015352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28574 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|